Top Pharma Wholesale and Distribution Companies in Latam
Top Pharma Wholesale and Distribution Companies in Latam
Pharma Wholesale and Distribution News
Innovating Skin Care Treatments Through Drug Repurposing
Tuesday, June 23, 2026
Dermatologic therapy is undergoing a transformative shift, moving away from the lengthy and costly model of de novo drug discovery toward more efficient and targeted approaches. While the traditional model has achieved notable successes, it often fails to address rare or specialized skin conditions, as the small patient populations cannot justify the high investment required. A more agile and intelligent strategy is now taking center stage: drug repurposing. This approach identifies new therapeutic uses for existing, approved molecules and is rapidly becoming a key driver of innovation in underserved dermatologic indications. Far from being accidental, drug repurposing is a deliberate, sc
Latin America's Pharma Marketing Transformation Through Outsourcing
Friday, April 24, 2026
Pharmaceutical companies in Latin America are navigating a complex environment shaped by regulatory challenges, increased healthcare access, and competition. Medical advertising now requires scientific accuracy, cultural awareness, and compliance with regulations. To boost efficiency and communication standards, many companies are outsourcing medical advertising services, which encompass promotional and educational materials as well as regulatory submissions. This approach allows companies to utilize specialized teams in medical writing, regulatory compliance, and market analysis, while concentrating on their primary functions, such as research and manufacturing. Regiona
Advancing Oral Dosage Manufacturing through Microgranule Formulations
Monday, March 16, 2026
Fremont, CA: Pharmaceutical manufacturers are under increasing pressure to produce reliable oral medications, which is influencing their formulation and production strategies in the context of complex product pipelines and strict regulatory oversight. As patient expectations continue to rise, these manufacturers are actively exploring dosage methods that focus on flexibility and consistency in large-scale production. Microgranule formulations have gained attention for their capacity to support manufacturing environments that demand precision and adaptability. Organizations are assessing therapeutic performance alongside compatibility within production ecosystems






